Recurring Fatigue After Biologic Administration: Patient-Reported Data from the Dutch Biologic Monitor.

ABSTRACT:

Background

Fatigue is a common problem in immune-mediated inflammatory disease (IMID) patients, significantly impacting their quality of life.

Objectives

In this study, we describe the pattern and characteristics of fatigue as a patient-reported adverse drug reaction (ADR) of biologics, and compared patient and treatment characteristics with patients reporting other ADRs or no ADRs.

Methods

In this cohort event monitoring study, the description and characteristics of fatigue reported as a possible ADR in the Dutch Biologic Monitor were assessed and analysed for commonly recurring themes or patterns. Baseline and treatment characteristics of patients with fatigue and patients reporting other ADRs or no ADRs were compared.

Results

Of 1382 participating patients,

SUBMITTER: van Lint JA 

PROVIDER: S-EPMC10287789 | biostudies-literature | 2023 Jul

REPOSITORIES: biostudies-literature